全球肠内营养市场:市场规模和占有率分析(依产品,年龄层,流程类型,应用和最终用户),工业需求预测(截至2030年)

全球肠内营养市场预计到 2023 年将达到 57.818 亿美元，预计 2024 年至 2030 年复合年增长率为 9.7%，到 2030 年将达到 109.637 亿美元。该市场的成长归因于老年人口的快速增加以及糖尿病、癌症、神经系统疾病和胃肠道疾病等慢性疾病的扩散。

标准制定引领产业

2023年，标准製剂占比最大，超过35%。

据估计，该类别在整个预测期内仍将保持主导地位。

这一趋势的一个主要因素是标准配方是专门为消化功能正常的人（无论是儿童还是成人）配製的。

儿科类别占据最大市场占有率

从应用来看，儿科类别在 2023 年占据了该行业最大的收入占有率。

预计在预测期内复合年增长率将维持在 9.8%。

这一趋势是由早产儿数量和儿童慢性病发病率的增加所推动的。

医院类别收入占比最大

2023年，医院品类在产业中占比最大，占总量的60%以上。

预计该类别在预测期内也将大幅成长。

医院中这些处方的使用迅速增加，主要是针对需要长期照护的患者，这是这项发展的主要驱动力。

北美主导肠内营养市场

预计到 2030 年，北美将继续领先市场，占有率约为 55%。这是因为 FDA 关于这些产品的法规在美国是标准化且执行良好的。

本报告分析了全球肠内营养市场，包括市场的基本结构和最新情况、主要促进和抑制因素以及全球、依地区和主要国家的市场规模前景（基于数量和价值） ，2017-2030），依类型、应用和最终用户划分的详细趋势、市场竞争的现状以及主要公司的概况。

目录

第一章 调查范围

第二章研究方法

第3章执行摘要

第四章 市场指标

第五章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因素影响分析
• 新型冠状病毒感染（COVID-19）的影响
• 波特五力分析

第六章 世界市场

• 概述
• 市场规模：依产品分类（2017-2030）
• 市场收入：依产品分类（2017-2030）
• 市场规模：依年龄组别划分（2017-2030）
• 市场收入：依年龄层划分（2017-2030）
• 市场规模：依流量类型划分（2017-2030）
• 市场收入：依流量类型分类（2017-2030）
• 市场规模：依应用划分（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场规模：依最终用户划分（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场规模：依地区划分（2017-2030）
• 市场收入：依地区（2017-2030）

第七章 北美市场

• 概述
• 市场规模：依产品分类（2017-2030）
• 市场收入：依产品分类（2017-2030）
• 市场规模：依年龄组别划分（2017-2030）
• 市场收入：依年龄层划分（2017-2030）
• 市场规模：依流量类型划分（2017-2030）
• 市场收入：依流量类型分类（2017-2030）
• 市场规模：依应用划分（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场规模：依最终用户划分（2017-2030）
• 市场收入：依最终用户分类（2017-2030）
• 市场规模：依国家划分（2017-2030）
• 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东和非洲（MEA）市场

第十二章 美国市场

• 概述
• 市场规模：依产品分类（2017-2030）
• 市场收入：依产品分类（2017-2030）
• 市场规模：依年龄组别划分（2017-2030）
• 市场收入：依年龄层划分（2017-2030）
• 市场规模：依流量类型划分（2017-2030）
• 市场回报：依流量类型划分（2017-2030）
• 市场规模：依应用划分（2017-2030）
• 市场收入：依应用分类（2017-2030）
• 市场规模：依最终用户划分（2017-2030）
• 市场收入：依最终用户分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

• 市场参与者及其提供的产品/服务的列表
• 主要企业竞争基准
• 主要公司的产品基准
• 近期策略发展状况

第三十章 公司简介

• Abbott Laboratories
• Danone S.A.
• Fresenius Kabi AG
• Nestle S.A.
• Victus Inc.
• Primus Pharmaceuticals Inc.
• Meiji Holdings Company Ltd.

第31章附录

The enteral feeding formulas market achieved a value of USD 5,781.8 million in 2023 and is projected to grow to USD 10,963.7 million by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030. This growth of the market can be credited to the surge in the elderly populace and the surge in the occurrence of chronic diseases, like diabetes, cancer, neurological diseases, and gastrointestinal diseases.

Factors That Are Boosting Market Growth

Enteral feeding formulas are specially formulated with a specific nutrient content to provide matching for malnourished individuals or individuals who are at risk of malnutrition. They have the necessary substances like vitamins, protein, and calories that one takes to live daily.

The WHO states that nearly half of the fatalities of children under five are related to undernutrition. This startling figure is flagrant, notably in middle-income countries.

Furthermore, the rising count of early births worldwide is propelling the acceptance of enteral feeding formulas to fulfill the nutritious needs of newborns, which is projected to boost the industry over the years. Moreover, the growing count of road accidents and wounds is set to propel the development of this industry.

Globally, road traffic accidents result in the deaths of roughly 1.2 million people annually.

Additionally, individuals injured in these accidents require time to heal, during which they may experience challenges with mobility and chewing.

Due to these factors, enteral feeding formulas become essential for providing necessary nutrition to injured individuals who are unable to eat conventionally.

Standard Formulas Are Leading the Industry

In 2023, standard formulas held the largest share of, more than 35% within the enteral feeding formulas industry.

The category is also estimated to continue to the dominant throughout the projection period.

The major factor for this trend is that standard formulas are precisely formulated for people with normal digestion, whether children or adults.

Standard formulas are adaptable as they can fulfill dual drives: as enteral feeding solutions and as oral supplements.

The Largest Share in The Market Was Held by The Pediatrics Category

In 2023, the pediatrics category generated the largest income share within the industry.

During the projection period, its development is projected to continue at a CAGR of 9.8% between.

This trend is propelled by a growing count of preterm births and a high occurrence of chronic situations among children.

Hospitals Category Accounts for Largest Revenue Share

In 2023, the Hospitals category held the largest industry share, of more than 60% of the total.

This category is also projected to witness significant development during the projection period.

The surge in the utilization of these formulas in hospitals, mainly for patients needing long-term care, is a major propeller of this development.

North America Dominates Enteral Feeding Formulas Market

North America is expected to continue leading the market with a share of around 55% in 2030. This will be due to the standardized and favorable FDA rules for these products in the U.S.

The US FDA has allowed infant formula manufacturers to increase the supply of pediatric formula by giving them temporary permission for enforcement discretion.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by age category
  • 1.4.3. Market size breakdown, by flow type
  • 1.4.4. Market size breakdown, by application
  • 1.4.5. Market size breakdown, by end user
  • 1.4.6. Market size breakdown, by region
  • 1.4.7. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Volume
  • 1.5.2. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Volume, by Product (2017-2030)
• 6.3. Market Revenue, by Product (2017-2030)
• 6.4. Market Volume, by Age Category (2017-2030)
• 6.5. Market Revenue, by Age Category (2017-2030)
• 6.6. Market Volume, by Flow Type (2017-2030)
• 6.7. Market Revenue, by Flow Type (2017-2030)
• 6.8. Market Volume, by Application (2017-2030)
• 6.9. Market Revenue, by Application (2017-2030)
• 6.10. Market Volume, by End User (2017-2030)
• 6.11. Market Revenue, by End User (2017-2030)
• 6.12. Market Volume, by Region (2017-2030)
• 6.13. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Volume, by Product (2017-2030)
• 7.3. Market Revenue, by Product (2017-2030)
• 7.4. Market Volume, by Age Category (2017-2030)
• 7.5. Market Revenue, by Age Category (2017-2030)
• 7.6. Market Volume, by Flow Type (2017-2030)
• 7.7. Market Revenue, by Flow Type (2017-2030)
• 7.8. Market Volume, by Application (2017-2030)
• 7.9. Market Revenue, by Application (2017-2030)
• 7.10. Market Volume, by End User (2017-2030)
• 7.11. Market Revenue, by End User (2017-2030)
• 7.12. Market Volume, by Country (2017-2030)
• 7.13. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Volume, by Product (2017-2030)
• 8.3. Market Revenue, by Product (2017-2030)
• 8.4. Market Volume, by Age Category (2017-2030)
• 8.5. Market Revenue, by Age Category (2017-2030)
• 8.6. Market Volume, by Flow Type (2017-2030)
• 8.7. Market Revenue, by Flow Type (2017-2030)
• 8.8. Market Volume, by Application (2017-2030)
• 8.9. Market Revenue, by Application (2017-2030)
• 8.10. Market Volume, by End User (2017-2030)
• 8.11. Market Revenue, by End User (2017-2030)
• 8.12. Market Volume, by Country (2017-2030)
• 8.13. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Volume, by Product (2017-2030)
• 9.3. Market Revenue, by Product (2017-2030)
• 9.4. Market Volume, by Age Category (2017-2030)
• 9.5. Market Revenue, by Age Category (2017-2030)
• 9.6. Market Volume, by Flow Type (2017-2030)
• 9.7. Market Revenue, by Flow Type (2017-2030)
• 9.8. Market Volume, by Application (2017-2030)
• 9.9. Market Revenue, by Application (2017-2030)
• 9.10. Market Volume, by End User (2017-2030)
• 9.11. Market Revenue, by End User (2017-2030)
• 9.12. Market Volume, by Country (2017-2030)
• 9.13. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Volume, by Product (2017-2030)
• 10.3. Market Revenue, by Product (2017-2030)
• 10.4. Market Volume, by Age Category (2017-2030)
• 10.5. Market Revenue, by Age Category (2017-2030)
• 10.6. Market Volume, by Flow Type (2017-2030)
• 10.7. Market Revenue, by Flow Type (2017-2030)
• 10.8. Market Volume, by Application (2017-2030)
• 10.9. Market Revenue, by Application (2017-2030)
• 10.10. Market Volume, by End User (2017-2030)
• 10.11. Market Revenue, by End User (2017-2030)
• 10.12. Market Volume, by Country (2017-2030)
• 10.13. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Volume, by Product (2017-2030)
• 11.3. Market Revenue, by Product (2017-2030)
• 11.4. Market Volume, by Age Category (2017-2030)
• 11.5. Market Revenue, by Age Category (2017-2030)
• 11.6. Market Volume, by Flow Type (2017-2030)
• 11.7. Market Revenue, by Flow Type (2017-2030)
• 11.8. Market Volume, by Application (2017-2030)
• 11.9. Market Revenue, by Application (2017-2030)
• 11.10. Market Volume, by End User (2017-2030)
• 11.11. Market Revenue, by End User (2017-2030)
• 11.12. Market Volume, by Country (2017-2030)
• 11.13. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Volume, by Product (2017-2030)
• 12.3. Market Revenue, by Product (2017-2030)
• 12.4. Market Volume, by Age Category (2017-2030)
• 12.5. Market Revenue, by Age Category (2017-2030)
• 12.6. Market Volume, by Flow Type (2017-2030)
• 12.7. Market Revenue, by Flow Type (2017-2030)
• 12.8. Market Volume, by Application (2017-2030)
• 12.9. Market Revenue, by Application (2017-2030)
• 12.10. Market Volume, by End User (2017-2030)
• 12.11. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Volume, by Product (2017-2030)
• 13.3. Market Revenue, by Product (2017-2030)
• 13.4. Market Volume, by Age Category (2017-2030)
• 13.5. Market Revenue, by Age Category (2017-2030)
• 13.6. Market Volume, by Flow Type (2017-2030)
• 13.7. Market Revenue, by Flow Type (2017-2030)
• 13.8. Market Volume, by Application (2017-2030)
• 13.9. Market Revenue, by Application (2017-2030)
• 13.10. Market Volume, by End User (2017-2030)
• 13.11. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Volume, by Product (2017-2030)
• 14.3. Market Revenue, by Product (2017-2030)
• 14.4. Market Volume, by Age Category (2017-2030)
• 14.5. Market Revenue, by Age Category (2017-2030)
• 14.6. Market Volume, by Flow Type (2017-2030)
• 14.7. Market Revenue, by Flow Type (2017-2030)
• 14.8. Market Volume, by Application (2017-2030)
• 14.9. Market Revenue, by Application (2017-2030)
• 14.10. Market Volume, by End User (2017-2030)
• 14.11. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Volume, by Product (2017-2030)
• 15.3. Market Revenue, by Product (2017-2030)
• 15.4. Market Volume, by Age Category (2017-2030)
• 15.5. Market Revenue, by Age Category (2017-2030)
• 15.6. Market Volume, by Flow Type (2017-2030)
• 15.7. Market Revenue, by Flow Type (2017-2030)
• 15.8. Market Volume, by Application (2017-2030)
• 15.9. Market Revenue, by Application (2017-2030)
• 15.10. Market Volume, by End User (2017-2030)
• 15.11. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Volume, by Product (2017-2030)
• 16.3. Market Revenue, by Product (2017-2030)
• 16.4. Market Volume, by Age Category (2017-2030)
• 16.5. Market Revenue, by Age Category (2017-2030)
• 16.6. Market Volume, by Flow Type (2017-2030)
• 16.7. Market Revenue, by Flow Type (2017-2030)
• 16.8. Market Volume, by Application (2017-2030)
• 16.9. Market Revenue, by Application (2017-2030)
• 16.10. Market Volume, by End User (2017-2030)
• 16.11. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Volume, by Product (2017-2030)
• 17.3. Market Revenue, by Product (2017-2030)
• 17.4. Market Volume, by Age Category (2017-2030)
• 17.5. Market Revenue, by Age Category (2017-2030)
• 17.6. Market Volume, by Flow Type (2017-2030)
• 17.7. Market Revenue, by Flow Type (2017-2030)
• 17.8. Market Volume, by Application (2017-2030)
• 17.9. Market Revenue, by Application (2017-2030)
• 17.10. Market Volume, by End User (2017-2030)
• 17.11. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Volume, by Product (2017-2030)
• 18.3. Market Revenue, by Product (2017-2030)
• 18.4. Market Volume, by Age Category (2017-2030)
• 18.5. Market Revenue, by Age Category (2017-2030)
• 18.6. Market Volume, by Flow Type (2017-2030)
• 18.7. Market Revenue, by Flow Type (2017-2030)
• 18.8. Market Volume, by Application (2017-2030)
• 18.9. Market Revenue, by Application (2017-2030)
• 18.10. Market Volume, by End User (2017-2030)
• 18.11. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Volume, by Product (2017-2030)
• 19.3. Market Revenue, by Product (2017-2030)
• 19.4. Market Volume, by Age Category (2017-2030)
• 19.5. Market Revenue, by Age Category (2017-2030)
• 19.6. Market Volume, by Flow Type (2017-2030)
• 19.7. Market Revenue, by Flow Type (2017-2030)
• 19.8. Market Volume, by Application (2017-2030)
• 19.9. Market Revenue, by Application (2017-2030)
• 19.10. Market Volume, by End User (2017-2030)
• 19.11. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Volume, by Product (2017-2030)
• 20.3. Market Revenue, by Product (2017-2030)
• 20.4. Market Volume, by Age Category (2017-2030)
• 20.5. Market Revenue, by Age Category (2017-2030)
• 20.6. Market Volume, by Flow Type (2017-2030)
• 20.7. Market Revenue, by Flow Type (2017-2030)
• 20.8. Market Volume, by Application (2017-2030)
• 20.9. Market Revenue, by Application (2017-2030)
• 20.10. Market Volume, by End User (2017-2030)
• 20.11. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Volume, by Product (2017-2030)
• 21.3. Market Revenue, by Product (2017-2030)
• 21.4. Market Volume, by Age Category (2017-2030)
• 21.5. Market Revenue, by Age Category (2017-2030)
• 21.6. Market Volume, by Flow Type (2017-2030)
• 21.7. Market Revenue, by Flow Type (2017-2030)
• 21.8. Market Volume, by Application (2017-2030)
• 21.9. Market Revenue, by Application (2017-2030)
• 21.10. Market Volume, by End User (2017-2030)
• 21.11. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Volume, by Product (2017-2030)
• 22.3. Market Revenue, by Product (2017-2030)
• 22.4. Market Volume, by Age Category (2017-2030)
• 22.5. Market Revenue, by Age Category (2017-2030)
• 22.6. Market Volume, by Flow Type (2017-2030)
• 22.7. Market Revenue, by Flow Type (2017-2030)
• 22.8. Market Volume, by Application (2017-2030)
• 22.9. Market Revenue, by Application (2017-2030)
• 22.10. Market Volume, by End User (2017-2030)
• 22.11. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Volume, by Product (2017-2030)
• 23.3. Market Revenue, by Product (2017-2030)
• 23.4. Market Volume, by Age Category (2017-2030)
• 23.5. Market Revenue, by Age Category (2017-2030)
• 23.6. Market Volume, by Flow Type (2017-2030)
• 23.7. Market Revenue, by Flow Type (2017-2030)
• 23.8. Market Volume, by Application (2017-2030)
• 23.9. Market Revenue, by Application (2017-2030)
• 23.10. Market Volume, by End User (2017-2030)
• 23.11. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Volume, by Product (2017-2030)
• 24.3. Market Revenue, by Product (2017-2030)
• 24.4. Market Volume, by Age Category (2017-2030)
• 24.5. Market Revenue, by Age Category (2017-2030)
• 24.6. Market Volume, by Flow Type (2017-2030)
• 24.7. Market Revenue, by Flow Type (2017-2030)
• 24.8. Market Volume, by Application (2017-2030)
• 24.9. Market Revenue, by Application (2017-2030)
• 24.10. Market Volume, by End User (2017-2030)
• 24.11. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Volume, by Product (2017-2030)
• 25.3. Market Revenue, by Product (2017-2030)
• 25.4. Market Volume, by Age Category (2017-2030)
• 25.5. Market Revenue, by Age Category (2017-2030)
• 25.6. Market Volume, by Flow Type (2017-2030)
• 25.7. Market Revenue, by Flow Type (2017-2030)
• 25.8. Market Volume, by Application (2017-2030)
• 25.9. Market Revenue, by Application (2017-2030)
• 25.10. Market Volume, by End User (2017-2030)
• 25.11. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Volume, by Product (2017-2030)
• 26.3. Market Revenue, by Product (2017-2030)
• 26.4. Market Volume, by Age Category (2017-2030)
• 26.5. Market Revenue, by Age Category (2017-2030)
• 26.6. Market Volume, by Flow Type (2017-2030)
• 26.7. Market Revenue, by Flow Type (2017-2030)
• 26.8. Market Volume, by Application (2017-2030)
• 26.9. Market Revenue, by Application (2017-2030)
• 26.10. Market Volume, by End User (2017-2030)
• 26.11. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Volume, by Product (2017-2030)
• 27.3. Market Revenue, by Product (2017-2030)
• 27.4. Market Volume, by Age Category (2017-2030)
• 27.5. Market Revenue, by Age Category (2017-2030)
• 27.6. Market Volume, by Flow Type (2017-2030)
• 27.7. Market Revenue, by Flow Type (2017-2030)
• 27.8. Market Volume, by Application (2017-2030)
• 27.9. Market Revenue, by Application (2017-2030)
• 27.10. Market Volume, by End User (2017-2030)
• 27.11. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Volume, by Product (2017-2030)
• 28.3. Market Revenue, by Product (2017-2030)
• 28.4. Market Volume, by Age Category (2017-2030)
• 28.5. Market Revenue, by Age Category (2017-2030)
• 28.6. Market Volume, by Flow Type (2017-2030)
• 28.7. Market Revenue, by Flow Type (2017-2030)
• 28.8. Market Volume, by Application (2017-2030)
• 28.9. Market Revenue, by Application (2017-2030)
• 28.10. Market Volume, by End User (2017-2030)
• 28.11. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Abbott Laboratories
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Danone S.A.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Fresenius Kabi AG
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Nestle S.A.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Victus Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Primus Pharmaceuticals Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Meiji Holdings Company Ltd.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports